| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Children's Hospital Boston, Boston, MA;
2 New England Research Institute, Watertown, MA;
3 University of Miami Miller School of Medicine, Miami, FL;
4 Washington University, St Louis, MO;
5 Children's Hospital of Pittsburgh, Pittsburgh, PA;
6 Stanford University, Palo Alto, CA;
7 Children's Memorial Hospital, Chicago, IL;
8 Texas Children's Hospital, Houston, TX
* Corresponding author; email: tp.singh{at}cardio.chboston.org
Background—In patients with dilated cardiomyopathy (DCM), the magnitude of cardiac remodeling often correlates with the clinical severity of heart failure. We sought to determine if measures of left ventricular (LV) dilation and systolic dysfunction in children with DCM at the time of listing for cardiac transplantation are associated with survival while waiting for and early after transplant.
Methods and Results—We analyzed echocardiographic data obtained within 6 months of listing for heart transplant and clinical data from 261 children with DCM who were included in both the Pediatric Cardiomyopathy Registry and the Pediatric Heart Transplant Study. Median time to listing after diagnosis was 1.9 months and to transplant after listing was 0.8 months. There were 42 deaths (29 waiting and 13 within 6 months after transplant). We found a significant agedependent association of LV end-diastolic dimension z-score (n=204, 31 deaths) with death controlling for race, transplant status and medical insurance. The association was strongest for infants < 6 months old at diagnosis (hazard ratio 1.47, P=0.008) and was not significant in children older than 5 years at diagnosis. A similar interaction was identified between age and LV end-systolic dimension z-score (P=0.04). Neither LV function nor mass was associated with death, overall or in subgroups.
Conclusions—The severity of LV dilation at listing for heart transplant is associated with outcome in infants and young children with DCM; the severity of LV systolic dysfunction is not. These findings should be considered in risk-stratification of these children at listing.
Key Words: cardiomyopathy echocardiography heart failure pediatrics transplantation
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |